BioDiaspora

BioDiaspora's risk assessment technology enables global leaders to accurately predict and anticipate how emerging infectious disease threats will spread around the world. This capability was scientifically validated during the 2009 H1N1 influenza pandemic and published in the New England Journal of Medicine. BioDiaspora is extensively used by United States Centers for Disease Control, World Health Organization, Public Health Agency of Canada, and other leading institutions that seek to mitigate against the health and economic risks of infectious diseases.